Covid antivirals

Pharmaceuticals roundup 2022


Following the huge success of vaccines and treatments for covid-19, companies are upping their investment in R&D and dealmaking

Tedros Adhanom Ghebreyesus

The end of a long race?


The finishing line of the Covid-19 pandemic may be in sight, but we mustn’t stop running just yet

Didier Raoult

French inquiry censures lab that promoted hydroxychloroquine to treat Covid


Report raises awkward questions about prominent study on antimalarial conducted in Didier Raoult’s lab

The Coronavirus Pandemic and the Future: Virology, Epidemiology, Translational Toxicology and Therapeutics

Introduction: the coronavirus pandemic and the future

This series of Chemistry World reports is part of a forth coming e-book and hardback to be published by the Royal Society of Chemistry. The book was motivated by a desire on the part of the editors and the authors to produce a body of information on the new and deadly coronavirus about which the world was largely uninformed and for which it was totally unprepared. 

Shinagawa station in busy morning rush hour



Originally developed to treat flu and marketed in Japan as Avigan, promising Covid-19 trial results have seen countries stockpiling this medication by the millions

Source:  © StreetVJ /